Evidence map›Paper›PMID 39853395›Full record

ReviewDie Ophthalmologie2025

[Differential diagnoses of central serous chorioretinopathy : Is that really a central serous chorioretinopathy?]

C Lange, J Aschauer, H Hufnagel, L Pauleikhoff, Retina.net CSC-Registry-Studie Gruppe

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Die Ophthalmologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Interventions for central serous chorioretinopathy: a network meta-analysis.The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

C LangeDepartment of Ophthalmology, St. Franziskus Hospital, Münster, Deutschland. clemens.lange@augen-franziskus.de.
J AschauerDepartment of Ophthalmology, St. Franziskus Hospital, Münster, Deutschland.
H HufnagelDepartment of Ophthalmology, St. Franziskus Hospital, Münster, Deutschland.
L PauleikhoffDepartment of Ophthalmology, University Medical Center Hamburg-Eppendorf, Hamburg, Deutschland.
Retina.net CSC-Registry-Studie Gruppe

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The accurate diagnosis of central serous chorioretinopathy (CSC) and its distinction from differential diagnoses is crucial for effective patient counseling and treatment. This is achieved through a targeted patient history and multimodal imaging, which distinguish CSC from other ocular diseases also characterized by subretinal fluid and changes in the retinal pigment epithelium. In this article we identify the key differential diagnoses of CSC and illustrate the characteristic differential diagnostic features of each disease. The differential diagnoses of CSC can be categorized into eight groups: 1) (neo)vascular choroidal diseases, 2) retinal diseases, 3) inflammatory diseases of the posterior segment, 4) benign and malignant ocular tumors, 5) malignant hematological diseases, 6) genetic disorders, 7) ocular developmental anomalies and 8) medication-related and toxic retinal changes.

Indexed as

Central Serous ChorioretinopathyDiagnosis, DifferentialFluorescein AngiographyHumansTomography, Optical CoherenceCentral serous chorioretinopathyDifferential diagnosesMacular diseaseMultimodal imagingSubretinal fluid

Identifiers

PMID39853395

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.